NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969,248 | -1.1% | 9,515 | -2.1% | 0.56% | +3.5% |
| Q2 2023 | $980,390 | -21.9% | 9,715 | -28.8% | 0.54% | -25.1% |
| Q1 2023 | $1,254,671 | +1.8% | 13,638 | +0.4% | 0.72% | -4.4% |
| Q4 2022 | $1,232,188 | +24.3% | 13,582 | +4.2% | 0.75% | +13.2% |
| Q3 2022 | $991,000 | +2.9% | 13,037 | +14.5% | 0.66% | +5.7% |
| Q2 2022 | $963,000 | +8.2% | 11,387 | +12.3% | 0.63% | +22.1% |
| Q1 2022 | $890,000 | +1.7% | 10,137 | +1.4% | 0.52% | +1.2% |
| Q4 2021 | $875,000 | +10.3% | 9,998 | +3.1% | 0.51% | -0.6% |
| Q3 2021 | $793,000 | -5.7% | 9,698 | +5.2% | 0.51% | -13.7% |
| Q2 2021 | $841,000 | +9.8% | 9,215 | +2.8% | 0.59% | +3.9% |
| Q1 2021 | $766,000 | -9.3% | 8,965 | +0.2% | 0.57% | -24.7% |
| Q4 2020 | $845,000 | – | 8,945 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |